Inventor · disambiguated record
Jeanne Cheung
Also filed as: CHEUNG JEANNE
8 granted patents·26 pending applications·1,358 citations·filing 2001–2025
88Inventor score
Top patents by PatentIndex Score
34 records- 0196US9920123B2Anti-PD-L1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2016·Granted Mar 20, 2018·30 cites·30 claims
- 0295US8217149B2Anti-PD-L1 antibodies, compositions and articles of manufactureIRVING BRYAN·Filed 2009·Granted Jul 10, 2012·1.3k cites·61 claims
- 0392US2025084185A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2024·Application pending·0 cites
- 0490US2024309111A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2024·Application pending·0 cites
- 0589US2024076404A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2023·Application pending·0 cites
- 0686US2023203194A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2022·Application pending·0 cites
- 0785US2023287127A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2023·Application pending·0 cites
- 0883US10570213B2Methods of treating cancers using PD-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2016·Granted Feb 25, 2020·2 cites·31 claims
- 0983US7579440B2Mammalian cytokines; related reagentsSCHERING CORP·Filed 2004·Granted Aug 25, 2009·5 cites·3 claims
- 1083US7148330B2Binding compounds for IL-27SCHERING CORP·Filed 2001·Granted Dec 12, 2006·5 cites·14 claims
- 1182US2022306766A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2022·Application pending·0 cites
- 1280US2022002437A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2021·Application pending·0 cites
- 1378US2025382370A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2025·Application pending·0 cites
- 1478US2025154282A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2025·Application pending·0 cites
- 1577US2021189004A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2021·Application pending·0 cites
- 1676US8691953B2Binding compounds for IL-27TIMANS JACQUELINE C·Filed 2011·Granted Apr 8, 2014·1 cites·8 claims
- 1776US8080392B2IL-D80 polynucleotidesTIMANS JACQUELINE C·Filed 2011·Granted Dec 20, 2011·1 cites·9 claims
- 1875US2020392249A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2020·Application pending·0 cites
- 1973US2020131276A1Methods of treating cancers using pd-1 axis binding antagonists and taxanesGENENTECH INC·Filed 2020·Application pending·0 cites
- 2073US2021032345A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2020·Application pending·0 cites
- 2171US7906622B2IL-D80 polypeptides and IL-27SCHERING CORP·Filed 2009·Granted Mar 15, 2011·0 cites·8 claims
- 2267US2015322153A1Anti-pd-l1 antibodies and articles of manufactureGENENTECH INC·Filed 2014·Application pending·0 cites
- 2367US2019016807A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2018·Application pending·0 cites
- 2467US2014170658A1Mammalian cytokines; related reagentsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 2565US2014065135A1Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunityGENENTECH INC·Filed 2013·Application pending·0 cites
- 2662US2013045202A1Anti-pd-l1 antibodies and articles of manufactureGENENTECH INC·Filed 2012·Application pending·0 cites
- 2762US2013045201A1Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunityGENENTECH INC·Filed 2012·Application pending·0 cites
- 2862US2013045200A1Methods of using anti-pd-l1 antibodies and their use to treat infection resulting from t-cell dysfunctionGENENTECH INC·Filed 2012·Application pending·0 cites
- 2960US2016222117A1Nucleic acid encoding anti-pd-l1 antibodiesGENENTECH INC·Filed 2015·Application pending·0 cites
- 3055US2025044288A1Cellular assays and methods to assess mhc-peptide-tcr interactions and kineticsGENENTECH INC·Filed 2022·Application pending·0 cites
- 3153US2015190506A1Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonistsGENENTECH INC·Filed 2014·Application pending·0 cites
- 3248US2018303936A1Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonistsGENENTECH INC·Filed 2018·Application pending·0 cites
- 3344US2017290913A1Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonistsGENENTECH INC·Filed 2017·Application pending·0 cites
- 3440US2016166685A1Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonistsGENENTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeanne Cheung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →